Latest filing published 08 Jun 2021 for Estee Lauder Companies INC, €679k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +0.3%Entry US$11.22 · Close at T+365 US$11.25
- -9.7%Entry US$10.40 · Close at T+365 US$9.39
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Irvine O. Hockaday Jr.: trading record in brief
Filings by Irvine O. Hockaday Jr. span 5 companies, the busiest being Estee Lauder Companies Inc, Aquila Inc and Aratana Therapeutics, Inc. We count 69 filings; the first trade dates from 30 December 2005 and the latest from 7 June 2021.
Market trades split into 2 purchases (€130k) and 21 sales (€10.4M). On balance, insiders were net sellers of €10.3M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 18 share grants and 21 option exercises. Since January 2021: no purchases and 2 sales on the market.
The newest entry dates from 8 June 2021: an open-market sale of €679k, in Estee Lauder Companies Inc. The last purchase on record was published on 3 November 2011, which is 5,484 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Irvine O. Hockaday Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,740 shares@ US$302.23100.0% of flowClass A Common StockSEC:0001001250-21-000086:0
- 3,000 shares@ US$295.556.5% of flowClass A Common StockSEC:0001001250-21-000022:0
- 2,329 shares@ US$143.398.7% of flowClass A Common StockSEC:0001001250-20-000147:0
- 1,905 shares@ US$190.999.4% of flowClass A Common StockSEC:0001001250-20-000147:1
- 4,234 shares@ US$255.0828.0% of flowClass A Common StockSEC:0001001250-20-000147:2
- 2,000 shares@ US$200.6411.1% of flowClass A Common StockSEC:0001001250-20-000047:0
- 3,400 shares@ US$192.6918.6% of flowClass A Common StockSEC:0001001250-20-000017:0
- 600 shares@ US$193.393.3% of flowClass A Common StockSEC:0001001250-20-000017:1
- 82,985 sharesCommon StockSEC:0001209191-19-042720:0
- 4,500 shares0Common StockSEC:0001209191-19-035633:0
- 1,800 sharesClass A Common StockSEC:0001001250-19-000056:0
- 2,906 shares@ US$126.024.5% of flowClass A Common StockSEC:0001001250-19-000042:0
- 2,094 shares@ US$78.362.0% of flowClass A Common StockSEC:0001001250-19-000042:1
- 5,000 shares@ US$170.1510.4% of flowClass A Common StockSEC:0001001250-19-000042:2
- 2,603 shares@ US$78.362.5% of flowClass A Common StockSEC:0001001250-19-000042:3
- 3,972 shares@ US$84.354.1% of flowClass A Common StockSEC:0001001250-19-000042:4
- 4,374 shares@ US$71.333.8% of flowClass A Common StockSEC:0001001250-19-000042:5
- 6,103 shares@ US$170.2612.7% of flowClass A Common StockSEC:0001001250-19-000042:6
- 4,747 shares@ US$171.319.9% of flowClass A Common StockSEC:0001001250-19-000042:7
- 99 shares@ US$172.090.2% of flowClass A Common StockSEC:0001001250-19-000042:8
- 1,500 shares@ US$155.312.8% of flowClass A Common StockSEC:0001001250-19-000018:0
- 1,700 shares@ US$137.572.5% of flowClass A Common StockSEC:0001001250-18-000082:0
- 4,500 shares0Common StockSEC:0001209191-18-044448:0
- 8,500 shares@ US$121.688.5% of flowClass A Common StockSEC:0001001250-17-000112:0
- 1,900 shares@ US$105.341.6% of flowClass A Common StockSEC:0001001250-17-000064:0
25 of 69 declarations
